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We report on a case of necrotizing keratoscleritis in primary Sjogren’s syndrome. A 66-year-old female patient who 
was complaining of ocular pain, tearing and decreased vision in her right eye for the previous two days was admitted 
to our hospital. Visual acuity in the right eye was hand movement, and initial examination showed a 3.0 × 1.8 mm 
uveal mass bulging through a corneoscleral melting site in the nasal region of the right eye. Positive anti-nuclear an-
tibody was identified at a titer of 1:320 with a speckled pattern, and both Sjogren’s syndrome A and Sjogren’s syn-
drome B antibody tests were positive, with titers >200 U/mL. A technetium 99m pertechnetate salivary scan re-
vealed chronic sialoadenitis in the submandibular glands. We diagnosed the lesion as necrotizing keratoscleritis 
due to primary Sjogren’s syndrome. A corneoscleral patch graft was performed, followed by immunosuppression in-
cluding oral cyclosporin and topical prednisolone. During a follow-up period of 12 months, the corneoscleral graft 
was well maintained with no recurrence. 
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Sjogren’s syndrome is a chronic autoimmune disorder af-
fecting mainly middle-aged women. It is characterized by 
lymphocytic infiltration and destruction of the exocrine 
glands (mainly the salivary and lacrimal glands), resulting 
in dry mouth and eyes [1]. Although keratoconjunctivitis 
sicca is the major ocular manifestation in Sjogren’s syn-
drome, severe corneal lesions with or without inflammation 
have also been rarely reported [2,3]. We describe a case of 
necrotizing keratoscleritis associated with primary Sjogren’s 
syndrome.
Case Report
A 66-year-old woman was admitted complaining of ocular 
pain, tearing, and decreased vision in her right eye for the 
previous two days. She had hypertension and diabetes melli-
tus and had received a cataract operation through a superior 
corneal incision in the right eye five years previous. She had 
been treated for dry eye syndrome and recurrent infectious 
keratitis for the past two years at a private clinic, but she had 
not received any prescription for antibiotic treatment during 
the most recent two months. In the initial examination, the 
patient’s corrected visual acuity was hand movement oculus 
dexter (OD). Slit lamp examination showed a 3.0 × 1.8 mm uveal 
mass bulging through a corneoscleral melting site in the nasal 
region of the right eye. Surrounding stromal opacity with 
corneal neovascularization and hypopyon were noted (Fig. 
1). The patient had only superficial epithelial keratitis in the 
opposite eye. Chest X-ray, complete blood count, liver func-
tion test, renal function test, and coagulation profile were 
performed along with examination of autoimmune labo-
ratory markers including anti-nuclear antibody (ANA), anti- 
neutrophil cytoplasmic antibody, rheumatoid arthritis (RA) 
factor, Sjogren’s syndrome A (SSA) and Sjogren’s syndrome 
B (SSB), anti-dsDNA, anti-Smith, anti-ribonecleo protein, 
anti-centromere, anti-cardiolipid, and anti-Scl-70 antibodies. 
An emergent corneoscleral patch graft was performed. The 
results of the Gram-stained smears, KOH mounting, and bac-
terial and fungus cultures conducted pre- and intra-operatively Korean J Ophthalmol Vol.25, No.4, 2011
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Fig. 1. Slit lamp photographs. (A) A 3 × 1.8 mm mass of uveal tissue was observed through a corneoscleral melting site. (B) 
Twelve months later, the corneoscleral patch graft was maintained without inflammation.
were all negative. Laboratory studies showed an elevated eo-
sinophil level (9.3%), positive RA factor as determined by at 
a titer of 169 IU/mL, and positive ANA at a titer of 1:320 
with a speckled pattern. Both SSA and SSB antibody tests 
were positive at titers >200 U/mL. Other laboratory findings 
were normal, and the patient did not have any articular 
symptoms. A technetium 99m pertechnetate salivary scan re-
vealed chronic sialoadenitis in the submandibular glands. 
Therefore, we diagnosed the lesion as necrotizing kerato-
scleritis due to primary Sjogren’s syndrome, and started im-
munosuppressive therapy including oral cyclosporin A 
(Cipol-N; Jongkeun Pharmacy, Seoul, Korea) and topical 1% 
prednisolone acetate (Pred Forte; Allergan, Irvine, CA, USA). 
Topical steroid application was maintained every hour for 
one month, was tapered to every four hours after two months, 
and the patient was slowly weaned from the drug by six 
months. Oral cyclosporine A was maintained at 200 mg for 
two months and tapered off over four months. Twelve 
months later, the previous corneoscleral patch graft was 
well maintained with no recurrence. Visual acuity was hand 
movement OD.
Discussion
 Most patients with scleritis have immune-mediated diseases, 
and up to half of affected individuals have an identifiable sys-
temic illness. Rheumatoid arthritis is the most commonly as-
sociated systemic disease in patients with scleritis, followed 
by Wegener’s granulomatosis, relapsing polychondritis, sys-
temic lupus erythematosus, inflammatory bowel disease, and 
polyarteritis nodosa [4]. In the case presented here, autoimmune 
markers, chest X-ray, and systemic symptoms of the patient 
showed no evidence of this autoimmune diseases.
Sjogren's syndrome is a slowly progressing autoimmune 
disease, observed in 0.5% to 1.0% of the population. Systemic 
features, resulting from cutaneous, respiratory, renal, hepatic, 
neurologic, and vascular involvement, often occur. Corticosteroids, 
cyclophosphamide, and nucleoside analogues are reserved 
for severe extraglandular manifestations of Sjogren's syn-
drome [1]. 
 Previously, Ahmadi-Simab et al. [5]
 reported a case of 
successfully treated refractory anterior scleritis in primary 
Sjogren’s syndrome using rituximab. Cohen [2] reported two 
cases of sterile corneal perforation after cataract surgery in 
Sjogren’s syndrome, and Vivino et al. [3] reported a case of 
repeated corneal melting and ulceration as the initial pre-
sentation of primary Sjogren's syndrome. However, to our 
knowledge, this is the first report of necrotizing kerato-
scleritis in primary Sjogren’s syndrome. 
 In this case, corneoscleral perforation had developed only 
two days after the initial symptoms first occurred. This rapid 
progression might have been caused by previous corneoscl-
eral thinning due to recurrent inflammation of the lesion. We 
were able to rule out infection via pre- and intra-operative 
smear and culture of the affected lesion and diagnosed the le-
sion as being due to primary Sjogren’s syndrome via sero-
logic examination, sialoscintigraphy, and typical symptoms. 
A corneoscleral patch graft was performed and followed by 
immunosuppression including oral cyclosporin and topical 
prednisolone. An oral steroid was not administered because 
the patient also had uncontrolled diabetes mellitus. In con-
clusion, based on this experience, for clinically suspected ne-
crotizing keratoscleritis, evaluation for Sjogren’s syndrome 
is recommended.
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